High glucose induced VEGF expression via PKC and ERK in glomerular podocytes

被引:136
作者
Hoshi, S
Nomoto, K
Kuromitsu, J
Tomari, S
Nagata, M [1 ]
机构
[1] Univ Tsukuba, Inst Clin Med, Dept Pathol, Tsukuba, Ibaraki 3058575, Japan
[2] Univ Tsukuba, Inst Basic Med Sci, Dept Pathol, Tsukuba, Ibaraki 3058575, Japan
[3] Eisai & Co Ltd, Tsukuba Res Labs, Ibaraki, Japan
关键词
diabetic nephropathy; podocyte; vascular endothelial growth factor; protein kinase C; extracellular signal-regulated kinase; activator protein-1; high glucose;
D O I
10.1006/bbrc.2001.6138
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Podocytes are the major site of vascular endothelial growth factor (VEGF) production in the kidney, and up-regulation of VEGF plays a critical role in the progression of diabetic nephropathy. Using a differentiated mouse podocyte cell line, we investigated the roles of protein kinase C (PKC) and extracellular signal-regulated kinase (ERK) on the expression of VEGF under high glucose conditions. High glucose induced up-regulation of VEGF mRNA and protein expression in podocytes via activation of PKC (PKC-alpha and -betaII isoforms) and ERK. High glucose stimulated [H-3]leucine incorporation in the podocytes. High glucose and the PKC stimulator, phorbol 12-myristate 13-acetate (PMA) induced activator protein-1 (AP-1)-dependent transcriptional activity and expression of VEGF. In addition, these phenomena were blocked by specific inhibitors of PKC (GF10902X) and ERK kinase (PD98059). These observations suggested that high glucose-induced VEGF expression in podocytes was largely mediated through PKC and ERK pathways that may be involved in diabetic nephropathy. (C) 2002 Elsevier Science.
引用
收藏
页码:177 / 184
页数:8
相关论文
共 42 条
  • [1] Role of vascular endothelial growth factor in diabetic vascular complications
    Aiello, LP
    Wong, JS
    [J]. KIDNEY INTERNATIONAL, 2000, 58 : S113 - S119
  • [2] PD-098059 IS A SPECIFIC INHIBITOR OF THE ACTIVATION OF MITOGEN-ACTIVATED PROTEIN-KINASE KINASE IN-VITRO AND IN-VIVO
    ALESSI, DR
    CUENDA, A
    COHEN, P
    DUDLEY, DT
    SALTIEL, AR
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (46) : 27489 - 27494
  • [3] VASCULAR-PERMEABILITY FACTOR MESSENGER-RNA AND PROTEIN EXPRESSION IN HUMAN KIDNEY
    BROWN, LF
    BERSE, B
    TOGNAZZI, K
    MANSEAU, EJ
    VANDEWATER, L
    SENGER, DR
    DVORAK, HF
    ROSEN, S
    [J]. KIDNEY INTERNATIONAL, 1992, 42 (06) : 1457 - 1461
  • [4] Role of vascular endothelial growth factor in diabetic nephropathy
    Cha, DR
    Kim, NH
    Yoon, JW
    Jo, SK
    Cho, WC
    Kim, HK
    Won, NH
    [J]. KIDNEY INTERNATIONAL, 2000, 58 : S104 - S112
  • [5] Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes
    Coimbra, TM
    Janssen, U
    Gröne, HJ
    Ostendorf, T
    Kunter, U
    Schmidt, H
    Brabant, G
    Floege, J
    [J]. KIDNEY INTERNATIONAL, 2000, 57 (01) : 167 - 182
  • [6] Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes
    Cooper, ME
    Vranes, D
    Youssef, S
    Stacker, SA
    Cox, AJ
    Rizkalla, B
    Casley, DJ
    Bach, LA
    Kelly, DJ
    Gilbert, RE
    [J]. DIABETES, 1999, 48 (11) : 2229 - 2239
  • [7] INCREASE IN DIACYLGLYCEROL MASS IN ISOLATED GLOMERULI BY GLUCOSE FROM DENOVO SYNTHESIS OF GLYCEROLIPIDS
    CRAVEN, PA
    DAVIDSON, CM
    DERUBERTIS, FR
    [J]. DIABETES, 1990, 39 (06) : 667 - 674
  • [8] THE ROLE OF THE GLOMERULAR EPITHELIAL-CELL IN THE MAINTENANCE OF THE GLOMERULAR-FILTRATION BARRIER
    DANIELS, BS
    [J]. AMERICAN JOURNAL OF NEPHROLOGY, 1993, 13 (05) : 318 - 323
  • [9] De Vriese A, 2001, J AM SOC NEPHROL, V12, P993, DOI 10.1681/ASN.V125993
  • [10] Molecular biology of diabetic glomerulosclerosis
    Del Prete, D
    Anglani, F
    Ceol, M
    D'Angelo, A
    Forino, M
    Vianello, D
    Baggio, B
    Gambaro, G
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 1998, 13 : 20 - 25